Belinda Cochrane

988 total citations
14 papers, 476 citations indexed

About

Belinda Cochrane is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Physiology. According to data from OpenAlex, Belinda Cochrane has authored 14 papers receiving a total of 476 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 4 papers in Epidemiology and 4 papers in Physiology. Recurrent topics in Belinda Cochrane's work include Chronic Obstructive Pulmonary Disease (COPD) Research (12 papers), Asthma and respiratory diseases (4 papers) and Chronic Disease Management Strategies (3 papers). Belinda Cochrane is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (12 papers), Asthma and respiratory diseases (4 papers) and Chronic Disease Management Strategies (3 papers). Belinda Cochrane collaborates with scholars based in Australia, United Kingdom and United States. Belinda Cochrane's co-authors include Evan Atlantis, Paul Fahey, Sheree Smith, Hak‐Kim Chan, Bruce K. Rubin, Sandra D. Anderson, Iven H Young, Evangelia Daviskas, Matthew T. Naughton and Richard Wood‐Baker and has published in prestigious journals such as CHEST Journal, BMJ Open and BMC Health Services Research.

In The Last Decade

Belinda Cochrane

12 papers receiving 460 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Belinda Cochrane Australia 7 347 128 111 80 58 14 476
C Dowson New Zealand 6 261 0.8× 62 0.5× 131 1.2× 57 0.7× 55 0.9× 7 351
Jiaxi Yu China 9 226 0.7× 121 0.9× 112 1.0× 49 0.6× 52 0.9× 17 384
Jillian Greene Canada 5 217 0.6× 139 1.1× 35 0.3× 30 0.4× 60 1.0× 8 421
Sara Buttery United Kingdom 13 370 1.1× 157 1.2× 108 1.0× 67 0.8× 42 0.7× 37 600
Gwendolyn J. McDonald United States 4 207 0.6× 48 0.4× 100 0.9× 65 0.8× 56 1.0× 7 378
Monique van Vliet Netherlands 11 269 0.8× 89 0.7× 80 0.7× 35 0.4× 46 0.8× 14 383
Li Whye Cindy Ng Australia 7 267 0.8× 114 0.9× 55 0.5× 55 0.7× 26 0.4× 12 405
Silvia Peruzza Italy 7 177 0.5× 186 1.5× 68 0.6× 17 0.2× 32 0.6× 8 384
J. Perriot France 14 217 0.6× 246 1.9× 49 0.4× 17 0.2× 75 1.3× 94 540
H.C.G. Kemper Netherlands 4 259 0.7× 122 1.0× 36 0.3× 52 0.7× 26 0.4× 11 367

Countries citing papers authored by Belinda Cochrane

Since Specialization
Citations

This map shows the geographic impact of Belinda Cochrane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Belinda Cochrane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Belinda Cochrane more than expected).

Fields of papers citing papers by Belinda Cochrane

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Belinda Cochrane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Belinda Cochrane. The network helps show where Belinda Cochrane may publish in the future.

Co-authorship network of co-authors of Belinda Cochrane

This figure shows the co-authorship network connecting the top 25 collaborators of Belinda Cochrane. A scholar is included among the top collaborators of Belinda Cochrane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Belinda Cochrane. Belinda Cochrane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Martin, Allison, Robert J. Hancox, Catherina L. Chang, et al.. (2025). Acute effects of low-dose bisoprolol on lung function and blood pressure in COPD patients. ERJ Open Research. 12(2). 591–2025.
2.
3.
Cochrane, Belinda, et al.. (2021). The Oxygen project: a prospective study to assess the effectiveness of a targeted intervention to improve oxygen management in hospitalised patients. Internal Medicine Journal. 51(5). 660–665. 3 indexed citations
4.
Cochrane, Belinda. (2020). Pleurisy and pulmonary embolism: physician sees through patient eyes. Internal Medicine Journal. 50(4). 498–501.
5.
Natali, Delphine, et al.. (2020). Screening for comorbidities in COPD. Breathe. 16(1). 190315–190315. 9 indexed citations
6.
Mannan, Haider, et al.. (2019). Does device matter for inhaled therapies in advanced chronic obstructive pulmonary disease (COPD)? A comparative trial of two devices. BMC Research Notes. 12(1). 94–94. 3 indexed citations
7.
Cochrane, Belinda, Jann Foster, Robert D. Boyd, & Evan Atlantis. (2016). Implementation challenges in delivering team-based care (‘TEAMcare’) for patients with chronic obstructive pulmonary disease in a public hospital setting: a mixed methods approach. BMC Health Services Research. 16(1). 347–347. 7 indexed citations
8.
Atlantis, Evan & Belinda Cochrane. (2015). The association of dietary intake and supplementation of specific polyunsaturated fatty acids with inflammation and functional capacity in chronic obstructive pulmonary disease. International Journal of Evidence-Based Healthcare. 14(2). 53–63. 15 indexed citations
9.
Atlantis, Evan & Belinda Cochrane. (2014). The association of dietary intake and supplementation of specific polyunsaturated fatty acids with inflammation and functional capacity outcomes in chronic obstructive pulmonary disease: a systematic review protocol. The JBI Database of Systematic Reviews and Implementation Reports. 12(11). 197–211. 1 indexed citations
10.
Atlantis, Evan, Paul Fahey, Belinda Cochrane, & Sheree Smith. (2013). Bidirectional Associations Between Clinically Relevant Depression or Anxiety and COPD. CHEST Journal. 144(3). 766–777. 255 indexed citations
11.
Atlantis, Evan, Paul Fahey, Belinda Cochrane, Gary Wittert, & Sheree Smith. (2013). Endogenous testosterone level and testosterone supplementation therapy in chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis. BMJ Open. 3(8). e003127–e003127. 46 indexed citations
12.
Cochrane, Belinda, Stephen Quinn, E. Haydn Walters, & Ian Young. (2011). Investigating the adverse respiratory effects of beta‐blocker treatment: six years of prospective longitudinal data in a cohort with cardiac disease. Internal Medicine Journal. 42(7). 786–793. 4 indexed citations
13.
Wood‐Baker, Richard, Belinda Cochrane, & Matthew T. Naughton. (2009). Cardiovascular mortality and morbidity in chronic obstructive pulmonary disease: the impact of bronchodilator treatment. Internal Medicine Journal. 40(2). 94–101. 30 indexed citations
14.
Daviskas, Evangelia, Sandra D. Anderson, Belinda Cochrane, et al.. (2005). Inhaled mannitol for the treatment of mucociliary dysfunction in patients with bronchiectasis: Effect on lung function, health status and sputum. Respirology. 10(1). 46–56. 99 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026